首页>
外国专利>
FVIIA PROTEIN FACTOR WITH AN INCREASED HALF-PERIOD FOR PREVENTION AND TREATMENT OF BLEEDING, AND ITS DOSAGE MODES
FVIIA PROTEIN FACTOR WITH AN INCREASED HALF-PERIOD FOR PREVENTION AND TREATMENT OF BLEEDING, AND ITS DOSAGE MODES
展开▼
机译:半衰期延长的FVIIA蛋白因子的预防和治疗及其剂量模式
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to dosing regimens with half-life extended Factor VIIa (FVIIa) for prophylactic and “on-demand” treatment of bleeding, as well as for preventing a bleeding episode during or after surgery in patients with congenital or acquired bleeding disorders. The present invention further relates to the use of half-life extended FVIIa for treating or preventing blood loss in patients without bleeding disorders in situations of hemorrhage, i.e., due to trauma or surgery. Another aspect of the invention is the treatment of acquired haemophilia.
展开▼